Search alternatives:
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
221
All data points from Fig 9.
Published 2025“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”
-
222
All data points from Fig 7.
Published 2025“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”
-
223
All data points from Fig 6.
Published 2025“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”
-
224
Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro.
Published 2009“…Curves represent mean change in optical density (OD) at 30-s intervals. (E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
-
225
-
226
-
227
-
228
-
229
-
230
Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>.
Published 2015“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”
-
231
Amplitude for A/L = 0.29.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
232
Amplitude for A/L = 0.338.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
233
Amplitude for A/L = 0.02.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
234
Amplitude for A/L = 0.03.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
235
-
236
-
237
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
238
-
239
-
240